Literature DB >> 15586798

Endoscopic management of failed frontal sinus obliteration.

Rakesh K Chandra1, David W Kennedy, James N Palmer.   

Abstract

BACKGROUND: Frontal sinus obliteration (FSO) traditionally has represented the final stage in the algorithm for difficult to manage frontal sinus disease. In addition, FSO has been used in selected cases of frontal sinus trauma. However, this procedure has been associated with failure in 5-10% of cases. Advances in surgical instrumentation and image-guided surgical navigation have permitted endoscopic management of these failures.
METHODS: Eleven patients presenting with failure of a previously performed FSO were managed endoscopically with the assistance of image-guided surgical navigation.
RESULTS: Initial frontal sinus pathology included chronic inflammatory disease in six patients and frontal sinus trauma in two patients. Two patients underwent obliteration after neurosurgical frontal craniotomy and one patient underwent obliteration after curettage of a frontal sinus ossifying fibroma. Frontal sinuses were obliterated with fat in eight cases, bone chips in two cases, and bone cement in one case. The mean time interval to FSO failure was 11.1 years (range, 4 months-35 years). The etiology of failure included mucocele in eight patients, chronic frontal sinusitis in two patients, and Pott's puffy tumor in one patient. All 11 patients were managed endoscopically, of which 3 patients underwent a trans-septal frontal sinusotomy. Two patients required revision endoscopic surgery, but all were patent at last follow-up (mean, 14.8 months).
CONCLUSION: Endoscopic management of failed FSO may be performed safely. These approaches are viable alternatives to open revision procedures in the management of failed FSO.

Entities:  

Mesh:

Year:  2004        PMID: 15586798

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  1 in total

1.  Management and Surveillance of Frontal Sinus Violation following Craniotomy.

Authors:  Alexander Farag; Marc R Rosen; Natalie Ziegler; Ryan A Rimmer; James J Evans; Christopher J Farrell; Gurston G Nyquist
Journal:  J Neurol Surg B Skull Base       Date:  2019-01-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.